SAB Biotherapeutics Inc.
Organization details
- Legal name
- SAB Biotherapeutics Inc.
- Former names
- Big Cypress Acquisition Corp.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Miami Beach
- Headquarters state / province
- Florida
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- SABS
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001833214
- EIN
- 85-3899721
Board of directors
-
Andrew Moin · DirectorSince 2023
-
Christine E. Hamilton · DirectorSince 2023
-
David Charles Link · DirectorSince 2024
-
David Link · DirectorSince 2025
-
David Zaccardelli · DirectorSince 2026
-
Eddie Joe Sullivan · Director · PRESIDENTSince 2023
-
Erick Lucera · DirectorSince 2023
-
Helen K. Ellias · DirectorSince 2023
-
Jay S. Skyler · DirectorSince 2024
-
Jeffrey G. Spragens · DirectorSince 2023
-
John Petry · DirectorSince 2023
- Since 2026
-
Samuel J. Reich · Director · CEOSince 2023
-
Scott Giberson · DirectorSince 2024
-
William James Polvino · DirectorSince 2024
Chief executives
Director election results
Annual meeting of June 18, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
91.2%
-
91.3%
Board connections
5 of this board's directors also sit on 9 other boards. 8 are in the same sector.
-
AnaptysBio Inc. Same sectorvia Rita Jain
-
Avalo Therapeutics Inc. Same sectorvia Rita Jain
-
Beyond Air Inc. Same sectorvia Erick Lucera
-
Bone Biologics Corp Same sectorvia Erick Lucera
-
Celldex Therapeutics Inc. Same sectorvia Rita Jain
-
DexCom Inc. Same sectorvia Jay S. Skyler
-
First Tracks Biotherapeutics Inc. Same sectorvia Rita Jain
- via Christine E. Hamilton
-
Vor Biopharma Inc. Same sectorvia David Zaccardelli
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 17, 2026 | Alexandra Kropotova Officer (CHIEF MEDICAL OFFICER) | Shares withheld for tax | −473 | — | — |
| Jun 25, 2026 | Alexandra Kropotova Officer (CHIEF MEDICAL OFFICER) | Shares withheld for tax | −988 | — | — |
| Mar 24, 2026 | Alexandra Kropotova Officer (CHIEF MEDICAL OFFICER) | Shares withheld for tax | −988 | — | — |
| Dec 11, 2025 | Alexandra Kropotova Officer (CHIEF MEDICAL OFFICER) | Shares withheld for tax | −988 | — | — |
| Sep 29, 2025 | Andrew Moin Director | Option exercise | +1,740,000 | $1.75 | $3,045,000 |
| Sep 29, 2025 | Sessa Capital GP, LLC Director | Option exercise | +1,740,000 | $1.75 | $3,045,000 |
| Sep 19, 2025 | Alexandra Kropotova Officer (CHIEF MEDICAL OFFICER) | Shares withheld for tax | −1,977 | — | — |
| Mar 27, 2025 | Alexandra Kropotova Officer (CHIEF MEDICAL OFFICER) | Shares withheld for tax | −1,179 | — | — |
| Dec 18, 2024 | Alexandra Kropotova Officer (CHIEF MEDICAL OFFICER) | Shares withheld for tax | −9,072 | — | — |
| Dec 7, 2023 | Eddie Joe Sullivan Director, Officer (Chief Executive Officer) | Open-market purchase | +1,740 | $0.88 | $1,531 |
| Nov 30, 2023 | King Michael Officer (CHIEF FINANCIAL OFFICER) | Open-market purchase | +5,000 | $0.90 | $4,500 |
| Nov 29, 2023 | Samuel J. Reich Director, Officer (Executive Chairman) | Open-market purchase | +11,000 | $0.89 | $9,790 |
| Nov 24, 2023 | Sessa Capital IM GP, LLC Director | Option exercise | +4,584,571 | — | — |
| Nov 24, 2023 | Andrew Moin Director | Option exercise | +4,584,571 | — | — |
| Nov 24, 2023 | Helen K. Ellias Director | Option exercise | +2,857,142 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about SAB Biotherapeutics Inc.
Who is the CEO of SAB Biotherapeutics Inc.?
Eddie Joe Sullivan is SAB Biotherapeutics Inc.'s Chief Executive Officer.
How many directors are on SAB Biotherapeutics Inc.'s board?
SAB Biotherapeutics Inc.'s board has 15 directors: Andrew Moin, Christine E. Hamilton, David Charles Link, David Link, David Zaccardelli, Eddie Joe Sullivan, Erick Lucera, Helen K. Ellias, Jay S. Skyler, Jeffrey G. Spragens and 5 others.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="sab-biotherapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.